Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001012975-17-000650

Options or other derivatives

  • 10% owner bought 468,190.45 shares at $940.00 ($2,918,180)

From the SEC's structured data for this filing

Trades in this filing

Novartis Bioventures Ltd · 10% owner

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-21 Purchase : show line 1 in the form Series B Convertible Preferred Stock +3,104.45 $940.00 $2,918,180 3,104.45 I
2017-08-21 Purchase : show line 2 in the form Warrant +465,086 465,086 I
Loading xslF345X03/edgar.xml…